Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Boris Kovatchev
University of Virginia, Department: Psychiatry
Should you be removed from our database? Contact us at [email protected]. Read more below.
TypeZero Technologies, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Kovatchev, along with other researchers at the University of Virginia, developed technology related to software control in artificial pancreas. This technology has been licences to TypeZero Technologies, LLC, which is in the process of developing commercial-grade artificial pancreas software. This TypeZero technology, along with other technologies from other developers will be evaluated in this project.
The results of these experiments could effect the financial interests of TypeZero Techonolgies. As Dr. Kovatchev has a significant financial interest in TypeZero, it was determined that this financial interest could effect the design, conduct or report of this sponsored research.
Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial
Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial To be ultimately successful as optimal treatment for type 1 diabetes, the artificial pancreas needs to prove its safety and efficacy in long-term pivotal trials in the patient's natural environment. Based on our extensive track record and established technology, we now propose a multi-center project involving 9 research sites in the U.S. and Europe, designed to demonstrate improvement in the two key parameters of diabetes control: HbA1c and risk for hypoglycemia. In two consecutive studies we will: (i) demonstrate superior long-term safety and efficacy of the artificial pancreas compared to sensor-augmented pump therapy, and (ii) test the added benefits of a new forward-looking adaptive closed-loop control strategy. Our ultimate goal is to establish a new diabetes treatment paradigm: the artificial pancreas is not a single-function device; it is an adaptable wearable network surrounding the patient in a digital treatment ecosystem.
Filed on November 01, 2016.
Tell us what you know about Boris Kovatchev's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Boris Kovatchev filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Boris Kovatchev | University of Virginia | Conflict of Interest | TypeZero Technologies, LLC | Value cannot be readily determined |
| Boris Kovatchev | University of Virginia | Conflict of Interest | TypeZero LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.